Hims Hers Health is trading at $33.16 (+4.09%), with the move appearing mainly sector-driven.
- Healthcare rose 1.29% during regular trading.
- Investors may be carrying forward optimism from the August 10 results, which included 38% revenue growth and raised 2026 revenue guidance.
- No new company-specific announcement was identified for August 21, 2026; the latest listed release was August 19. Broader risk-on tone and recent FTC-related selling may also contribute, but no direct company catalyst was confirmed.